Model-Based Alternative Dosing Strategies for Subcutaneous Nivolumab to Improve Cost Effectiveness
{{output}}
Background: The increasing use of the immune checkpoint inhibitor nivolumab places a significant financial burden on healthcare systems, contributes to environmental concerns, and strains hospital capacities. The nivolumab averag... ...
